跳至主要内容
临床试验/NCT01881178
NCT01881178已完成不适用

The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein (NOPALEA)

Mark Mattie1 个研究点 分布在 1 个国家目标入组 287 人开始时间: 2013年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
287
试验地点
1
主要终点
HS-CRP

研究概览

简要总结

This study has been developed to investigate the anti-inflammatory effects of a commercial product (Nopalea) containing Prickly Pear Cactus Fruit Juice in healthy adults. The research method employs a double blind, placebo controlled, and time-series (repeat measures) design with high-sensitivity C-Reactive Protein (HS-CRP) serving as a marker for inflammation - testing for levels of CRP at time points: baseline (pre-test), 8 weeks (60 days) and 12 weeks (90 days). The final time point (i.e., 12 weeks) will serve as the post-test. It is expected that baseline CRP levels in healthy participants will decline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Live within traveling distance of the research center. Access to a telephone in their residence. Between 35 and 75 years of age Not currently ingesting Nopalea Not pregnant, planning to become pregnant, or nursing a child Not currently taking anti-inflammatory medications Medically stable - i.e. no recent major change in the last 3 weeks of prescription or non- prescription medication Not diagnosed with Type 1 Diabetes Not diagnosed with depression Not diagnosed with an acquired or congenital immune system deficiency

排除标准

  • 未提供

研究组 & 干预措施

Apricot

Active Comparator

Supplement: Apricot Juice

干预措施: NOPALEA (Dietary Supplement)

Nopalea

Experimental

Supplement: Nopalea

干预措施: NOPALEA (Dietary Supplement)

结局指标

主要结局

HS-CRP

时间窗: 12 weeks

次要结局

未报告次要终点

研究者

发起方
Mark Mattie
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Mark Mattie

Associate Professor

University of Bridgeport

研究点 (1)

Loading locations...

相似试验